James is responsible for the innovator and industry support provided by the Oxford AHSN . James has been working in the life science and healthcare sector for over 15 years in a range of roles focused on improving patient access to healthcare innovation. James holds a PhD in Regenerative Medicine and worked in pharma, SMEs and consulting in R&D, commercial and market access roles before joining the Oxford AHSN.
James has led on a portfolio of successful projects aimed at supporting the NHS to capitalise on innovative health technology including medicines, medtech and digital innovations.
James also leads the national Accelerated Access Collaborative programme focused on improving access to biologic therapies for severe asthma.